Revolutionary drug combination promises new hope for diabetes treatment
A groundbreaking study recently published in Science Translational Medicine reveals that a novel drug combination could significantly enhance the treatment of both type 1 and type 2 diabetes by regenerating insulin-producing cells in the pancreas. Understanding the breakthrough Researchers have discovered that combining exendin-4, a common diabetes medication, with harmine, a DYRK1A enzyme inhibitor, can […]